2000
DOI: 10.1001/archinte.160.7.913
|View full text |Cite
|
Sign up to set email alerts
|

Unresolved Issues in the Role of Cyclooxygenase-2 in Normal Physiologic Processes and Disease

Abstract: Originally suggested to function mainly in inflammatory situations, recent data have implied important roles for the cyclooxygenase-2 isoenzyme in reproductive biologic processes, renal and neurologic function, and the antithrombotic activities of endothelial cells. As cyclooxygenase-2-specific inhibitors have recently become available as analgesic and anti-inflammatory drugs, a comprehensive view of this rapidly evolving field is necessary to anticipate both the potential therapeutic benefits and toxic effect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
86
0
12

Year Published

2000
2000
2007
2007

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 143 publications
(98 citation statements)
references
References 114 publications
0
86
0
12
Order By: Relevance
“…Although NSAIDs inhibit both COX isoforms, selective inhibition of COX-2 results in decreased prostacyclin, a vasodilator and moderator of platelet activation, without reducing COX-1-dependent thromboxanes, contributors to platelet aggregation and vasoconstriction. 21,22 Emerging data support a varied role for COX-2 in the vascular bed, with important functions in vascular resistance, 23 late preconditioning, 24 endothelial function, 25,26 and atherogenesis. 27,28 Data from rat models of hypertension suggest that celecoxib may be associated with improvements in endothelial function and reductions in oxidative stress 29 ; neutral findings have been reported for rofecoxib and diclofenac.…”
Section: Discussionmentioning
confidence: 99%
“…Although NSAIDs inhibit both COX isoforms, selective inhibition of COX-2 results in decreased prostacyclin, a vasodilator and moderator of platelet activation, without reducing COX-1-dependent thromboxanes, contributors to platelet aggregation and vasoconstriction. 21,22 Emerging data support a varied role for COX-2 in the vascular bed, with important functions in vascular resistance, 23 late preconditioning, 24 endothelial function, 25,26 and atherogenesis. 27,28 Data from rat models of hypertension suggest that celecoxib may be associated with improvements in endothelial function and reductions in oxidative stress 29 ; neutral findings have been reported for rofecoxib and diclofenac.…”
Section: Discussionmentioning
confidence: 99%
“…Isto tem permitido o desenvolvimento de agentes que bloqueiam a atividade COX-2, especificamente em concentrações que apresentam mínimos efeitos COX-1. O mesmo composto pode funcionar como um inibidor COX-2 em baixas concentrações e inibidor competitivo da COX-1 quando em altas dosagens 16 . As bases moleculares para tais diferenças ainda não são completamente entendidas 10 ; c) A COX-1 é uma enzima presente na maioria dos tecidos.…”
Section: Ciclooxigenase (Cox)unclassified
“…Diante de hipovolemia, o sistema renina-angiotensina-aldosterona renal é ativado, o que contribui para vasoconstrição sistêmica e maior reabsorção de sódio e água, na tentativa de manter níveis tensionais adequados. Ao mesmo tempo, a angiotensina provoca síntese de prostaglandinas renais vasodilatadoras, as quais são sintetizadas às custas da COX-1 16 , a qual está presente no endotélio, glomérulo e ductos coletores renais. Assim o rim consegue manter RFG e FSR durante condições iniciais de vasoconstrição sistêmi-ca.…”
Section: Função Renalunclassified
See 2 more Smart Citations